EREG and cancer: Despite a number of EREG-related studies mainly focusing on the consequence of cancer cell-expressed ligands [18, 19], it remains unknown whether and how senescent stromal cell-derived EREG functions as a cancer-responsive factor in the TME niche, specifically regarding the potential of stromal EREG in driving malignant progression of human cancers.